MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > MIR KEY TO RETIREMENT/2ND SHORT

<< Previous

Bullboard Posts

Next >>

Comment by conservative2on Mar 13, 2021 4:21pm

273 Views

Post# 32793513

RE:MIR KEY TO RETIREMENT/2ND SHORT

I believe as you do August 202013. My only error in the past was not tweaking to the 80 plus cents and going out and back in at 30 cents. It has drifted downward as a result of not being supported. The covid plus FDA submission also took the wind out of the sail on the stock price. 20 20 is hindsight and no one could foreseen these developments. Having said all this, I believe FDA approval on the plus test will cause Medmira stock to sky rocket as the commercial investors buy into MIR. Hold tight. It will happen!! It will quite a wild ride!! Conservative2

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading